Suchergebnisse - "De Santo, Carmela"

PubPharm (78)

1

Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models

enthalten in: British journal of cancer | 2024

von Arshad, M. | Azad, A. | Chan, P. | +8

2

PARC : a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults

enthalten in: Frontiers in oncology | 2024

von Fenwick, N. | Weston, R. | Wheatley, K. | +27

3

NUCLEIC ACID CONSTRUCTS AND CELLS

enthalten in: Europäisches Patentamt | 2024

von MUSSAI FRANCIS | DE SANTO CARMELA

4

NUCLEIC ACID CONSTRUCTS AND CELLS

enthalten in: Europäisches Patentamt | 2024

von MUSSAI FRANCIS | DE SANTO CARMELA

5

NUCLEIC ACID CONSTRUCTS AND CELLS

enthalten in: Europäisches Patentamt | 2023

von MUSSAI FRANCIS | DE SANTO CARMELA

6

NUCLEIC ACID CONSTRUCTS AND CELLS

enthalten in: Europäisches Patentamt | 2023

von MUSSAI FRANCIS | DE SANTO CARMELA

7

Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment

enthalten in: Blood advances | 2023

von Panetti, S. | McJannett, N. | Fultang, L. | +15

8

A randomised evaluation of low-dose Ara-C plus pegylated recombinant arginase BCT-100 versus low dose Ara-C in older unfit patients with acute myeloid leukaemia : Results from the LI-1 trial

enthalten in: British journal of haematology | 2023

von Mussai, F. | De Santo, C. | Cheng, P. | +13

9

Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Stavrou, V. | Fultang, L. | Booth, S. | +20

10

FUSION PROTEINS WITH ARGINASE ACTIVITY

enthalten in: Europäisches Patentamt | 2022

von MUSSAI FRANCIS JAY | DE SANTO CARMELA

1
2
3
4
5
6
7
8
Nächster »
[8]